Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (11): 1013-1016.DOI: 10.3969/j.issn.1673-8640.2018.011.010

• Orginal Article • Previous Articles     Next Articles

Determination of human serum ouabain by UPLC-MS/MS and methodology comparison

ZHAO Yinxia1, OU Meixian1, QU Yi2, LU Youli1, ZHANG Meiwei1, LI Shuijun1   

  1. 1. Central Laboratory,Shanghai Xuhui Central Hospital,Shanghai 200031,China
    2. Department of Geriatrics,Shanghai Xuhui Central Hospital,Shanghai 200031,China
  • Received:2017-07-26 Online:2018-11-30 Published:2018-11-28

Abstract:

Objective To establish an ultra high performance liquid chromatography-tandem mass spectrometry(UPLC-MS/MS) for the determination of human serum ouabain. Methods High-specific UPLC-MS/MS was used. A deuterium-labeled ouabain-d3 was used as internal standard. Serum samples were prepared with solid phase extraction(SPE),and a reversed phase column was used for chromatography separation. The mass spectrometer was operated in negative-ion mode with electrospray ionization(ESI) source. Methodology validation included the evaluation of matrix effect,recovery,accuracy,within-run precision,between-run precision and stability. The established UPLC-MS/MS was used to determine serum ouabain in 40 hypertension patients and 20 healthy subjects (healthy control group). The results of UPLC-MS/MS were compared with those of enzyme-linked immunosorbent assay (ELISA). Results The UPLC-MS/MS had a linear range from 0.02 to 5.00 ng/mL. The lower limit of quantification (LLOQ) was 0.02 ng/mL. The matrix effect of pretreatment with ABN solid phase extraction column was the smallest. The recovery rate was high (85%). The accuracies of LLOQ,low-level (0.06 ng/mL),middle-level (0.6 ng/mL) and high-level (4 ng/mL) quality control materials were 108.0%,89.2%,101.0% and 103.0%,respectively. The within-run coefficients of variation (CV) were 2.87%,1.95% and 0.56%,and the between-run CV were 5.98%,1.90% and 0.75%. The samples placed at room temperature for 16 h were stable,and the processed samples placed in autosampler at room temperature for 48 h were stable. Both biases were <15%. The results showed that both healthy control and hypertension groups had undetectable serum ouabain level by the established UPLC-MS/MS. The levels were 0.096 ng/mL in hypertension group and 0.062 ng/mL in healthy control group when they were determined by ELISA. Ouabain standard materials at 5 different levels (0.02,0.05,0.10,0.20 and 0.50 ng/mL) were determined by UPLC-MS/MS. It showed a positive correlation between the results and the corresponding levels with good linearity(r2>0.99)and high accuracy. The results of 5 samples determined by ELISA were very close(0.024 9-0.029 6 ng/mL). Conclusions The level of serum ouabain is undetectable both in healthy control and hypertension groups by the established UPLC-MS/MS. There is difference for the results of serum ouabain determination between UPLC-MS/MS and ELISA.

Key words: Ouabain, Ultra high performance liquid chromatography-tandem mass spectrometry, Solid phase extraction, Enzyme-linked immunosorbent assay, Hypertension

CLC Number: